New therapeutic target identified for ALS
Published ahead of print in the online edition of the journal PNAS, the study establishes using segments of genetic material called antisense oligonucleotides — ASOs — to block the buildup and selectively degrade the toxic RNA that contributes to the most common form of ALS, without affecting the normal RNA produced from the same gene. …